Regeneron Pharmaceuticals 2023 JPMorgan Healthcare Conference Strategy Update

Regeneron Pharmaceuticals presented its strategy and business update at the J.P. Morgan Healthcare Conference in January 2023, featuring insights from CEO Leonard S. Schleifer. The presentation covered the company's pipeline including EYLEA, Dupixent, Libtayo, and other product candidates, along with forward-looking clinical and commercial developments.